US2017128416A1PendingUtilityA1

Oral administration of melanin for protection against radiation

Assignee: ALBERT EINSTEIN COLLEGE MEDICINE INCPriority: Mar 18, 2011Filed: Aug 8, 2016Published: May 11, 2017
Est. expiryMar 18, 2031(~4.6 yrs left)· nominal 20-yr term from priority
A61P 7/06A61P 7/04A61P 39/00A61P 29/00A61P 17/16A61P 17/00A61P 1/12A61P 1/08A61K 9/0095A61K 31/404A61K 31/198A61K 36/06A61K 31/136A61K 36/07A61K 31/05
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods and compositions are provided for alleviating and/or preventing one or more side effects associated with exposure to radiation in a subject exposed to radiation or at risk for exposure to radiation comprising oral administration to the subject of an amount of an edible source of melanin effective to alleviate a side effect associated with radiation.

Claims

exact text as granted — not AI-modified
1 - 26 . (canceled) 
     
     
         27 . An agent for computer tomography comprising a drinkable suspension containing at least 250 mg of a dried powdered edible source of melanin in a volume of at least 10 mL, wherein the edible source of melanin comprises  Auricularia auricular - judae.    
     
     
         28 . A method of reducing radiation damage from a computer tomography (CT) scan of a subject comprising administering the agent of  claim 27  to the subject prior to the CT scan

Join the waitlist — get patent alerts

Track US2017128416A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.